Aldebaran Financial Inc. Merck & Co., Inc. Transaction History

Aldebaran Financial Inc.

$80.2 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$87.44 - $112.11 $52,464 - $67,266	-600 Reduced 24.57%	1,842 $204,000
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $10,988 - $12,344	-130 Reduced 5.05%	2,442 $211,000
Q2 2022 Aug 01, 2022	SELL	$83.49 - $94.64 $125,234 - $141,960	-1,500 Reduced 36.84%	2,572 $233,000
Q1 2022 Apr 18, 2022	BUY	$73.51 - $82.4 $735 - $824	10 Added 0.25%	4,072 $334,000
Q4 2021 Feb 16, 2022	BUY	$72.28 - $90.54 $16,624 - $20,824	230 Added 6.0%	4,062 $311,000
Q3 2021 Oct 21, 2021	SELL	$71.68 - $78.83 $22,579 - $24,831	-315 Reduced 7.6%	3,832 $288,000
Q1 2021 May 03, 2021	BUY	$68.86 - $81.11 $17,215 - $20,277	250 Added 6.42%	4,147 $320,000
Q4 2020 Feb 05, 2021	SELL	$71.77 - $79.65 $80,310 - $89,128	-1,119 Reduced 22.31%	3,897 $319,000
Q3 2020 Oct 19, 2020	SELL	$73.18 - $82.95 $28,613 - $32,433	-391 Reduced 7.23%	5,016 $416,000
Q2 2020 Jul 20, 2020	SELL	$70.42 - $80.13 $404,351 - $460,106	-5,742 Reduced 51.5%	5,407 $418,000
Q1 2020 Apr 24, 2020	SELL	$63.36 - $87.82 $2,977 - $4,127	-47 Reduced 0.42%	11,149 $858,000
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $543 - $612	7 Added 0.06%	11,196 $1.02 Million
Q3 2019 Oct 21, 2019	SELL	$76.08 - $82.93 $100,958 - $110,048	-1,327 Reduced 10.6%	11,189 $936,000
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $558 - $652	8 Added 0.06%	12,516 $1.05 Million
Q1 2019 Apr 23, 2019	BUY	$69.58 - $79.36 $4,313 - $4,920	62 Added 0.5%	12,508 $1.04 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $521 - $605	8 Added 0.06%	12,446 $951,000
Q3 2018 Nov 08, 2018	BUY	$57.69 - $67.84 $461 - $542	8 Added 0.06%	12,438 $882,000
Q2 2018 Aug 10, 2018	BUY	$50.83 - $59.72 $457 - $537	9 Added 0.07%	12,430 $755,000
Q1 2018 Apr 24, 2018	SELL	$50.96 - $59.23 $40,360 - $46,910	-792 Reduced 5.99%	12,421 $677,000
Q4 2017 Mar 02, 2018	BUY	$51.62 - $61.64 $33,965 - $40,559	658 Added 5.24%	13,213 $743,000
Q3 2017 Nov 17, 2017	BUY	$58.67 - $63.13 $3,344 - $3,598	57 Added 0.46%	12,555 $804,000
Q2 2017 Aug 28, 2017	BUY	N/A	12,498	12,498 $801,000

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$25.8 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$21.4 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$12.3 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.82 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$6.1 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aldebaran Financial Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aldebaran Financial Inc. with notifications on news.

Account